☆ 4.5 Article

An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

Related references

Note: Only part of the references are listed.

Review Pharmacology & Pharmacy

COVID-19: Clinical status of vaccine development to date

Sunny Kumar et al.

Summary: COVID-19, caused by SARS-CoV-2, is a complex disease with no specific drugs available for treatment. Global vaccination is seen as the only hope for minimizing the severity and mortality. After extensive research and clinical trials, 165 vaccine candidates have been developed, with 28 approved for use and others in different stages of clinical trials. This comprehensive report aims to provide an up-to-date clinical trial status of all discovered vaccines, focusing on the approved candidates, as well as vaccination of medically distinct populations.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Add to Collection

Article Immunology

Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA vaccination in Individuals With Underlying Immune Dysregulation

Joseph M. Rocco et al.

Summary: The development of effective SARS-CoV-2 mRNA vaccines is a significant accomplishment, but continued surveillance and early recognition of adverse events are important, especially in at-risk populations.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Infectious Diseases

Patients presenting high fever with lymphadenopathy after COVID-19 vaccination were diagnosed with hemophagocytic lymphohistiocytosis

Dong Won Baek et al.

Summary: COVID-19 vaccination has led to a significant decrease in new infections and related deaths, but various adverse events, including hemophagocytic lymphohistiocytosis (HLH), have been reported. This study describes two cases of HLH following vaccination with mRNA-based and adenovirus vector vaccines, emphasizing the importance of early suspicion and management by clinicians to lower mortality rates.

INFECTIOUS DISEASES (2022)

Add to Collection

Letter Pathology

Haemophagocytic lymphohistiocytosis after ChAdOx1 nCoV-19 vaccination

Luke Attwell et al.

JOURNAL OF CLINICAL PATHOLOGY (2022)

Add to Collection

Letter Virology

Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination

Sylvia Ai et al.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Haemophagocytic lymphohistiocytosis following COVID-19 mRNA vaccination

Vernon Wu et al.

Summary: The development of COVID-19 vaccines is crucial in the fight against the pandemic, but there have been reports of rare complications, including HLH. Two cases of HLH after COVID-19 mRNA vaccination were reported, along with 50 suspected cases in the adverse event reporting system. The causal relationship between vaccination and HLH development remains uncertain.

BMJ CASE REPORTS (2022)

Add to Collection

Review Immunology

Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis

Han-qi Zhang et al.

Summary: This article summarizes the main pathogenesis and treatment methods of hemophagocytic lymphohistiocytosis (HLH).

IMMUNOLOGIC RESEARCH (2022)

Add to Collection

Article Medicine, General & Internal

A case of hemophagocytic lymphohistiocytosis after BNT162b2 COVID-19 (Comirnaty®) vaccination

Yoshitaka Shimada et al.

Summary: This article describes a rare case of hemophagocytic lymphohistiocytosis (HLH) in a patient with nephritic sclerosis associated with hypertension following mRNA COVID-19 vaccination. It emphasizes the importance of recognizing HLH as a rare complication of COVID-19 vaccination, especially in patients with a history of chronic renal failure and hypertension.

MEDICINE (2022)

Add to Collection

Article Immunology

Adult-Onset Familial Hemophagocytic Lymphohistiocytosis Presenting with Annular Erythema following COVID-19 Vaccination

Yifan He et al.

Summary: This article presents a patient who developed HLH after receiving a COVID-19 vaccine, emphasizing the need for caution in individuals with preexisting immune dysregulation or diseases not classified when receiving the vaccine. A review of genetic defects and cutaneous manifestations of HLH was also conducted.

VACCINES (2022)

Add to Collection

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in Adults or Hemophagocytic Lymphohistiocytosis: A Clinical Conundrum in Fully Vaccinated Adults With Breakthrough COVID-19 Infections

Hiba Narvel et al.

Summary: This is the first case of a fully vaccinated patient who developed hyperinflammatory syndrome with breakthrough COVID-19 infection after receiving the Spikevax/Moderna vaccine. The occurrence of MIS-A in adults, especially after COVID-19 vaccination, is rare and there is a lack of clear algorithms and guidelines for diagnosis and management.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Add to Collection

Review Rheumatology

Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic

Mehmet Soy et al.

Summary: Hemophagocytic syndrome (HPS) or hemophagocytic lymphohistiocytosis (HLH) is an acute systemic inflammatory disorder characterized by excessive cytokine production and hyperferritinemia. It can be primary, caused by genetic mutations, or secondary, triggered by underlying disorders like malignancies or infections. In COVID-19 patients, secondary HLH and cytokine storm may lead to severe symptoms such as progressive fever, cytopenia, ARDS, and organ failure. Early differentiation and classification are crucial for appropriate treatment strategies.

RHEUMATOLOGY INTERNATIONAL (2021)

Add to Collection

Review Rheumatology

Haemophagocytic syndrome and COVID-19

Soledad Retamozo et al.

Summary: HLH is a hyperferritinaemic hyperinflammatory syndrome characterized by decreased interferon gamma production and activated NK phenotype. Viruses are closely linked to the development of HLH, and the break of tolerance to self-antigens is considered a critical mechanism in immune-mediated conditions triggered by viral infections.

CLINICAL RHEUMATOLOGY (2021)

Add to Collection

Review Virology

A systematic meta-analysis of immune signatures in patients with COVID-19

Kun Liu et al.

Summary: A systematic meta-analysis found significant differences in circulatory immunological signatures, with IL-6 and IL-10 showing the most significant disparities. T cell-related immune signatures and various cytokines can be utilized as robust biomarkers in predicting disease severity.

REVIEWS IN MEDICAL VIROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

Isaac See et al.

Summary: Cases of CVST with thrombocytopenia following Ad26.COV2.S vaccination have been reported in the US, leading to serious outcomes. This case series may provide guidance for clinical management and further investigation into the potential relationship between Ad26.COV2.S vaccine and CVST with thrombocytopenia.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

Kate-Lynn Muir et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Hematology

Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination

Mouna Sassi et al.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Hematology

Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine

Syed Hamza Bin Waqar et al.

Summary: TTP, a rare hematologic threat, has been associated with COVID-19 mRNA vaccines during the COVID-19 pandemic, as seen in a case of a 69-year-old male with multiple comorbidities.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Article Immunology

High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses

Min Xie et al.

Summary: The study aimed to understand the immune response in COVID-19 patients with T cells showing both functional defects and hyperactivation. Elevated levels of sCD25 were found in severe cases, indicating insufficient anti-viral immunity and expansion of pro-inflammatory T cells. The mouse model and clinical observation confirmed the association between high sCD25 levels and disease severity.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Add to Collection

Letter Critical Care Medicine

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Qiurong Ruan et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Article Microbiology

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis

George Dimopoulos et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Allergy

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

Yang Yang et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Editorial Material Medicine, Research & Experimental

SARS-CoV-2: a storm is raging

Savannah F. Pedersen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Medicine, General & Internal

Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?

Violetta Opoka-Winiarska et al.

BMC MEDICINE (2020)

Add to Collection

Review Medical Laboratory Technology

Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Linlin Cheng et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

Add to Collection

Article Immunology

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Yong Xiong et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Chemistry, Medicinal

Validation studies of the site-directed docking program LibDock

Shashidhar N. Rao et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.